Results 81 to 90 of about 1,327 (186)

Plain Language Summary Publication: Efficacy and safety of rimegepant for the preventive treatment of migraine in Japan: A double‐blind, randomized controlled trial

Headache: The Journal of Head and Face Pain, Volume 66, Issue 4, Page 1002-1003, April 2026.
Shigekazu Kitamura, Yasuhiko Matsumori, Toshimasa Yamamoto, Tomofumi Ishikawa, Yuko Hoshino, Hiroki Yoshimatsu, Alexandra Thiry, Akio Arakawa, Robert Croop, Terence Fullerton, Fumihiko Sakai, Takao Takeshima   +11 more
wiley   +1 more source

Modified Tinea – A Mithering Problem [PDF]

, 2021
Eberconazole has an anti-inflammatory effect and in our experience, also has a better role in managing steroid-modified and facial lesions. Eberconazole has a better role in clearance of the lesions.
AS KUMAR, RAJ KIRIT EP
core   +1 more source

Situational prevention in migraine: are we doing the right thing?

The Journal of Headache and Pain
This commentary addresses the use of rimegepant for situational prevention in migraine management. While the approach of using prophylactic treatments during high-risk periods is not new, its application with rimegepant described by Lipton et al.
Lanfranco Pellesi, Paolo Martelletti
doaj   +1 more source

Review of the clinical experience and literature on GONB in paediatric headache clinic [PDF]

Objective: The aim of the study was to overview the evidence for administration of Greater Occipital Nerve Block (GONB) in children with chronic headache and evaluate the safety and benefits of the procedure.Methods: GONB was offered to patients where ...
Abu-Arafeh , Ishaq, Carragher, Raymond, MacLeod, Stewart, Morozova, Maria   +3 more
core   +1 more source

Efficacy and Safety of Rimegepant 75 mg Oral Tablet, a CGRP Receptor Antagonist, for the Acute Treatment of Migraine: A Randomized, Double-Blind, Placebo-Controlled Trial

Journal of Pain Research
Richard B Lipton,1 Alexandra Thiry,2 Beth A Morris,3 Robert Croop3 1Department of Neurology and the Montefiore Headache Center, Albert Einstein College of Medicine, Bronx, NY, USA; 2Biostatistics, Pfizer, Inc., New York, NY, USA; 3Clinical Operations (BM)
Lipton RB, Thiry A, Morris BA, Croop R
doaj  

Vascular models to study migraine:From human isolated blood vessels to vessel-on-chip [PDF]

In this thesis, the vascular effects of CGRP and novel pharmacological treatment of migraine targeting CGRP (receptors) are investigated. CGRP is a neuropeptide that is involved in migraine pathophysiology, but is also a potent vasodilator that can offer
de Vries, Tessa
core   +2 more sources

Safety of Rimegepant in Adults with Migraine and Anxiety, Depression, or Using Antidepressants: Analysis of a Multicenter, Long-Term, Open-Label Study

Pain and Therapy
Introduction Anxiety and depression are frequently associated with migraine, and antidepressant use can complicate treatment. These analyses assessed the safety and tolerability of rimegepant in participants with migraine and anxiety and/or depression ...
David Kudrow, Susan Hutchinson, Glenn C. Pixton, Terence Fullerton   +3 more
doaj   +1 more source

Pharmacological management of migraine:current strategies and future directions [PDF]

Introduction: Migraine is a complex neurological disorder that affects a significant portion of the global population. As traditional pharmacological approaches often fall short in alleviating symptoms, the development of innovative therapies has ...
Do, Thien Phu, Hougaard, Anders, Pellesi, Lanfranco   +2 more
core   +1 more source

What's in the pipeline for pediatric headache treatment?

Headache: The Journal of Head and Face Pain, Volume 66, Issue 2, Page 548-550, February 2026.
Amy A. Gelfand, Christina L. Szperka
wiley   +1 more source

Comparative effectiveness of erenumab versus rimegepant for migraine prevention using matching-adjusted indirect comparison

Journal of Comparative Effectiveness Research
Aim: To compare the efficacy of erenumab versus rimegepant as preventive treatment for patients with episodic and chronic migraine using an anchor-based matching-adjusted indirect comparison.
Ronan Mahon, Santosh Tiwari, Mirja Koch, Matias Ferraris, Keith A Betts, Yan Wang, Sophie Gao, Pascal Proot   +7 more
doaj   +1 more source